POL promoters, the Turakhia brothers are immensely experienced and well reputed. This capex in fermentation API by 300 CR market cap company is no mean feat. This company is bound to be rerated fabulously much before the ongoing capex which has lowered it’s return ratios, will start yielding fruits.
It also has quite a decent OTC portfolio for e-commerce… protein supplements and all. It’s a story worth tracking in microcap pharma space.
| Subscribe To Our Free Newsletter |
